These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38069585)

  • 21. Longterm Beneficial Effect of Canakinumab in Colchicine-resistant Familial Mediterranean Fever.
    Laskari K; Boura P; Dalekos GN; Garyfallos A; Karokis D; Pikazis D; Settas L; Skarantavos G; Tsitsami E; Sfikakis PP
    J Rheumatol; 2017 Jan; 44(1):102-109. PubMed ID: 28042127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is it possible to extend the dose interval of canakinumab treatment in children with familial Mediterranean fever? PeRA group experience.
    Kavrul Kayaalp G; Çağlayan Ş; Demirkan FG; Guliyeva V; Otar Yener G; Öztürk K; Demir F; Özdel S; Çakan M; Sönmez HE; Sözeri B; Aktay Ayaz N
    Pediatr Rheumatol Online J; 2023 Nov; 21(1):140. PubMed ID: 37996934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of canakinumab treatment on growth parameters in children with familial Mediterranean fever.
    Aydin EA; Baglan E; Kocamaz NG; Bagrul İ; Tuncez S; Ozdel S
    Clin Rheumatol; 2024 Jan; 43(1):387-392. PubMed ID: 37658934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-interleukin-1 treatment in 26 patients with refractory familial mediterranean fever.
    Kucuksahin O; Yildizgoren MT; Ilgen U; Ates A; Kinikli G; Turgay M; Erten S
    Mod Rheumatol; 2017 Mar; 27(2):350-355. PubMed ID: 27328763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Canakinumab for the treatment of children with colchicine-resistant familial Mediterranean fever: a 6-month open-label, single-arm pilot study.
    Brik R; Butbul-Aviel Y; Lubin S; Ben Dayan E; Rachmilewitz-Minei T; Tseng L; Hashkes PJ
    Arthritis Rheumatol; 2014 Nov; 66(11):3241-3. PubMed ID: 25049046
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of the Auto-inflammatory Disease Activity Index to monitor disease activity in patients with colchicine-resistant Familial Mediterranean Fever, Mevalonate Kinase Deficiency, and TRAPS treated with canakinumab.
    Koné-Paut I; Piram M; Benseler S; Kuemmerle-Deschner JB; Jansson A; Rosner I; Tommasini A; Murias S; Karadag O; Levy J; McCreddin S; Migliaccio M; De Benedetti F
    Joint Bone Spine; 2022 Nov; 89(6):105448. PubMed ID: 35944600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever.
    Gül A; Ozdogan H; Erer B; Ugurlu S; Kasapcopur O; Davis N; Sevgi S
    Arthritis Res Ther; 2015 Sep; 17(1):243. PubMed ID: 26337145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical Familial Mediterranean Fever Complicated with Gastrointestinal Amyloidosis Diagnosed due to Paroxysmal Arthralgia and Intractable Diarrhea, Successfully Treated with Tocilizumab.
    Aikawa E; Shimizu T; Koga T; Endo Y; Umeda M; Hori T; Irie J; Kuroda K; Eguchi M; Okamoto M; Tsuji S; Takatani A; Igawa T; Sumiyoshi R; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Kawakami A
    Intern Med; 2019 Jun; 58(12):1781-1785. PubMed ID: 30713308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of interleukin-1 inhibition in a cohort of patients with colchicine-resistant familial Mediterranean fever treated consecutively with anakinra and canakinumab.
    Druyan A; Giat E; Livneh A; Grossman C; Ben-Zvi I; Lidar M
    Clin Exp Rheumatol; 2021; 39 Suppl 132(5):75-79. PubMed ID: 34369359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Canakinumab as monotherapy for treatment of familial Mediterranean fever - first report in Central and Eastern Europe region.
    Jesenak M; Hrubiskova K; Kapustova L; Kostkova M; Banovcin P
    Bratisl Lek Listy; 2018; 119(4):198-200. PubMed ID: 29663815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical improvement with infliximab in a child with amyloidosis secondary to familial Mediterranean fever.
    Yüksel S; Yalçinkaya F; Acar B; Ozçakar ZB; Oztürk B; Ekim M
    Rheumatology (Oxford); 2006 Oct; 45(10):1307-8. PubMed ID: 16880190
    [No Abstract]   [Full Text] [Related]  

  • 32. Real-life data on tapering or discontinuation of canakinumab therapy in patients with familial Mediterranean fever.
    Karabulut Y; Gezer HH; Öz N; Esen İ; Duruöz MT
    Rheumatol Int; 2022 Dec; 42(12):2211-2219. PubMed ID: 36048189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fever of unknown origin and colchicine-sensitive amyloidosis: familial Mediterranean fever?].
    Schneider W; Wehmeier A
    Dtsch Med Wochenschr; 1989 Jun; 114(24):951-4. PubMed ID: 2731480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial.
    Koga T; Sato S; Miyamoto J; Hagimori N; Kawazoe Y; Arinaga K; Fukushima C; Yamamoto H; Kawakami A
    Trials; 2018 Dec; 19(1):715. PubMed ID: 30594222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful Therapy with Canakinumab and Mepolizumab for Familial Mediterranean Fever and Eosinophilic Pneumonia.
    Wand O; Kimhi O; Israeli-Shani L; Shitrit D
    Isr Med Assoc J; 2023 Aug; 25(8):573-574. PubMed ID: 37574898
    [No Abstract]   [Full Text] [Related]  

  • 36. Familial Mediterranean fever, review of the literature.
    Alghamdi M
    Clin Rheumatol; 2017 Aug; 36(8):1707-1713. PubMed ID: 28624931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Approach to the patients with inadequate response to colchicine in familial Mediterranean fever.
    Gül A
    Best Pract Res Clin Rheumatol; 2016 Apr; 30(2):296-303. PubMed ID: 27886801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Canakinumab in colchicine resistant familial Mediterranean fever and other pediatric rheumatic diseases.
    Çakan M; Karadağ ŞG; Ayaz NA
    Turk J Pediatr; 2020; 62(2):167-174. PubMed ID: 32419407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesothelioma in Familial Mediterranean Fever With Colchicine Intolerance: A Case Report and Literature Review.
    Talerico R; Cardillo C; De Vito F; Schinzari F; Soldato M; Giustiniani MC; Verrecchia E; Manna R
    Front Immunol; 2020; 11():889. PubMed ID: 32477360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial Mediterranean Fever without Fever.
    Hotta Y; Kawasaki T; Kotani T; Okada H; Ikeda K; Yamane S; Yamada N; Sekoguchi S; Isozaki Y; Nagao Y; Murotani M; Oyamada H
    Intern Med; 2020 May; 59(10):1267-1270. PubMed ID: 32051376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.